Corona Remedies Shares Jump 38% on Debut

1 Minute Read Listen to Article
Share:    

Dec 15, 2025 11:05

x
Corona Remedies shares debut with a 38% premium. IPO subscribed 137 times. Market valuation at Rs 8,996.65 crore. Details here.
New Delhi, Dec 15 (PTI) Shares of pharma firm Corona Remedies Ltd made a remarkable market debut on Monday, listing with a premium of over 38 per cent, against the issue price of Rs 1,062.

The stock started trading at Rs 1,452, a jump of 36.72 per cent from the issue price on the BSE. Later, it surged 41.14 per cent to Rs 1,499.

At the NSE, it listed with a premium of 38.41 per cent at Rs 1,470.


The company's market valuation stood at Rs 8,996.65 crore.

The initial public offering of Corona Remedies received 137.04 times subscription on the closing day of share sale on Wednesday last week.

The Rs 655.37-crore Initial Public Offering (IPO) had a price band of Rs 1,008-1,062 per share.

Headquartered in Ahmedabad, Corona Remedies is a pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas.
Share:    

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

See More >

Moneywiz Live!

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback